Protagenic Therapeutics Inc (NASDAQ:PTIX) Stock Is All Set To Gap Up After Earnings

August 19, 2021

The biopharmaceutical firm Protagenic Therapeutics Inc (NASDAQ:PTIX) has been in focus among investors during the premarket trading period and is already up by as much as 8% at the time of writing. There has been no fresh news about the company but earlier on this week Protagenic announced its financial results for the second fiscal quarter that ended on June 30, 2011. In light of the gains made by the…